In this study, we provide novel evidence that impaired PVAT metabolism causes a marked exacerbation of hypertension and increases vascular dysfunction in two types of BMP4-DKO mice treated with HFD or Ang II, suggesting that activating PVAT metabolism may be an alternative novel approach for hypertension. Here, BMP4 is linked to hypertensive disorder.